Medical News

RSS

Three ESRD products chosen for FDA's Innovation Pathway program

Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.

10 Apr 2012

UofL wins NIH grant for cardiac clinical research center

During his 18-year tenure at UofL, Dr. Roberto Bolli has generated more than $100 million in grants for basic research from the NIH. Today, Bolli joined with University of Louisville President James R. Ramsey to announce a new NIH grant he has won for clinical research, a seven-year, $3.4 million grant from the National Heart, Lung and Blood Institute to establish one of seven regional centers across the United States in the Cardiac Cell Therapy Research Network.

10 Apr 2012

Flextronics acquires Stellar Microelectronics

Flextronics today announced that it has completed its previously announced acquisition of Stellar Microelectronics.

10 Apr 2012

RegeneRx wins four patents in Israel, Mexico

RegeneRx Biopharmaceuticals, Inc. announced today that the Company has received an issued patent in Mexico and allowances of three additional patent applications in Mexico and Israel.

10 Apr 2012

ReCor Medical provides updated data from REDUCE Percutaneous Renal Denervation System study

ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

HDS signs LOI with PharmaLife to market Clotamin in Russia

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC are pleased to announce that HDS has signed a Letter of Intent with PharmaLife for placement of Clotamin with leading pharmacies in the Russian Federation.

10 Apr 2012

Preeclampsia Foundation to hold Promise Walks in May

May is Preeclampsia Awareness Month and to build awareness of preeclampsia, a life-threatening disorder of pregnancy and the post-partum period, thousands of families in 36 cities in the U.S. and Canada are participating in Promise Walks.

10 Apr 2012

OphthaliX completes CF101 preclinical studies on Anterior Uveitis

OphthaliX announced today the completion of preclinical studies, showing that its CF101 drug candidate is efficacious in treating Anterior Uveitis

10 Apr 2012

First Choice acquires FCMG

First Choice Healthcare Solutions, Inc. today announced its acquisition of First Choice Medical Group of Brevard, LLC, a multi-specialty medical group practice including orthopedics (both operative and non-operative), sports medicine, pain management and neurology located in Melbourne, Fla.

10 Apr 2012

Aristolochic acid exposure leads to kidney failure and UUC

Aristolochic acid (AA), a component of a plant used in herbal remedies since ancient times, leads to kidney failure and upper urinary tract cancer (UUC) in individuals exposed to the toxin.

10 Apr 2012

Walgreens declares quarterly dividend of 22.5 cents per share

The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.

10 Apr 2012

Spacelabs Healthcare launches qube patient monitor

Having received clearance under Section 510(k) from the U.S. Food and Drug Administration, Spacelabs Healthcare is adding the qube patient monitor to its Art of Monitoring portfolio. Inspired by the revolutionary style of the company's XPREZZON patient monitor, qube breaks with tradition to offer a fresh, new perspective in compact monitoring.

10 Apr 2012

States roundup: Aetna goes ahead with small biz coverage hike; 1.2M Texas kids without insurance; Legal immigrants join Mass. health plan

Despite criticism from the state insurance commissioner and several statewide consumer groups, Aetna said Thursday it's going ahead with a recent hike in health care premiums for small businesses. Aetna's new increases, which average 8 percent annually and took effect April 1, were deemed "unreasonable" this week by state Department of Insurance Commissioner David Jones.

10 Apr 2012

Australia-first meeting tackles unacceptable maternal and child health in Burma

Unacceptably high maternal and infant mortality rates in Burma are being addressed for the first time in Australia at a conference at the University of Sydney today.

9 Apr 2012

Fatty acids fight cancer spread

Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumors, preventing the advance to secondary stage cancers according to pharmacy researchers at the University of Sydney.

9 Apr 2012

New webinar series for healthcare suppliers

GS1 Australia and the National E-Health Transition Authority (NEHTA) are pleased to announce ‘Realise the Efficiency of the NPC’, a new free webinar for healthcare suppliers who want a better understanding of how to use the National Product Catalogue (NPC).

9 Apr 2012

Dementia sufferers and caregivers unhappy with quality of care

Dementia patients and their families have been asked to assess the quality of care available to them. Their reports are far from satisfactory. Alzheimer's Australia says dementia patients and their carers are being let down right across the health system. The Federal Government has promised to use the report to help decide how to improve the system.

9 Apr 2012

Berries may reduce Parkinson’s disease risk in men: Study

A new study has found that men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease. The study was published in the journal Neurology this week. It added that there was no such effect among women.

9 Apr 2012

FDA approves scan to detect Alzheimer’s disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

9 Apr 2012